Monday, March 9, 2009

Merck buys Schering-Plough

Markets rose on a rare stock buy out, but that enthusiasm did not last. Dow tried to extend the gains on the opening to 100, but couldn't. Dow & NAZ pulled back to modest losses while decliners led advancers almost 4-1.

S&P 500 FINANCIALS INDEX crawled back up 2 to the 83s. The Alerian MLP Index dropped 3 to the 167s as it's flirting with the lows of the year & not far from the Nov lows. REITs & junk bond funds were weak. In the last month, junk bond funds have lost most of their bear market rally gains made in the prior 2 months.


Alerian MLP Index --- YTD




Merck (MRK), Dow stock, will buy Schering-Plough (SGP) for $41B in a stock & cash deal to create the 2nd biggest drug company (behind Pfizer). But some SGP stockholders are complaining, they want a higher price.

Merck's $41 Billion Schering Buy to Add Experimental Drugs, Speed Research


McDonald's (MCD), Dow stock, reported same store sales were up 5.4% in Feb, in line with expectations. However, they cautioned that Q1 results will be hurt by foreign exchange adjustments & higher commodity costs. They remain optimistic about the long term, stock up 51¢ but down $2 from the earlier high.

Capital One (COF) became the latest bank to slash the div. The quarterly div was cut sharply to a nickel. A nickel or a penny has become the popular div level for most banks.

Warren Buffet in a CBNC interview gave a very gloomy assessment of the economy. He repeated the theme that it fell off a cliff, a popular comment. As usual, he is optimistic about the long run.

Markets look to be stuck in trench warfare. Banks are dead in the water & the auto companies will have to justify their existence to Congress in a couple of weeks.

No comments: